Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Experimental Vaccine
Sinovac Research and Development Co.,
Hand, Foot and Mouth Disease
1 trial -
Experimental continuous peripheral nerve blocks
United Therapeutics Europe Ltd
Lower Extremity Surgical Amputation
1 trial -
Experimental: Hyperslim
Vera Therapeutics
Venous Thromboembolism (VTE)
1 trial -
Febuxostat
Takeda
Gout
6 trials -
Fill out Questionnaire
Rhythm Pharmaceuticals Netherlands B.V.
Bradycardia
1 trial -
Fluoxetine + outpatient cognitive behavioral therapy
BRIGHT MINDS BIOSCIENCES INC.
Alcohol-Related Disorders
1 trial -
Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]
Sarepta Therapeutics
Duchenne Muscular Dystrophy
1 trial -
Group 1 Standard of Care
Pacira Ireland Limited
Retraction of Colostomy
1 trial -
Group A (the standard 2HRZE/4HR regimenοΌ
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Tuberculosis TB in Sputum: (+) Microscopy
1 trial -
Group C : Saline + propofol group
Hospital Authority, Hong Kong
Urologic Surgery
1 trial -
Hepatitis B vaccine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Hepatitis B Vaccination, HIV
1 trial -
Hiconcil 500 mg trde kapsule, Enterol 250 mg, gΓ©lules, Matched Placebo will consist in caspules similar to the 250 mg capsules of the Saccharomyces boulardii CNCM-I-745 but with no active ingredient
Biocodex
Patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis))
1 trial -
Hydrocortisone Acetate 1% Ointment
BRIGHT MINDS BIOSCIENCES INC.
Postoperative Sore Throat, Cough, Hoarseness
1 trial -
Induction of labor with PGE2
Guangzhou Virotech Pharmaceutical Co.,
Labor Induction
1 trial -
Intraosseous
Hospital Authority, Hong Kong
Cardiac Arrest
1 trial -
Intraosseous Morphine
Hospital Authority, Hong Kong
Pain Postoperative
1 trial -
Intravenous Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Obesity
1 trial -
Intravenous Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Fever
1 trial -
Intravenous Immunoglobulins, Human
The First People's Hospital of Lianyungang
Guillain-Barre Syndrome
1 trial -
Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients with Atrial Fibrillation
Rhythm Pharmaceuticals Netherlands B.V.
Arrhythmias, Cardiac
1 trial -
Intravenous Treprostinil
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
1 trial -
Intravenous fentanyl citrate
BRIGHT MINDS BIOSCIENCES INC.
Peer Review, Research
1 trial -
Intravenous ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Pain
3 trials -
Intravenous thrombolysis + edaravone
The First People's Hospital of Lianyungang
Ischemic Stroke
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources